AvantiCell Science company

AvantiCell delivers leading-edge solutions for customers wishing to evaluate bio-activity or bio-safety in a wide-range of test materials; from pharmaceuticals, traditional medicines and natural products to medical devices and nano-structured materials. AvantiCell solutions use advanced cell culture technology based on physiologically-relevant human and animal cells. AvantiCell supplies a growing range of human primary cell products which are accessible as cell isolates requiring re-culture within the customer's laboratory or in the form of pre-assembled, cryopreserved models. These products make cell-based analysis available to all customers in a plug-and-play format. AvantiCell also provides its expertise in a range of services ranging from off-the-shelf cell-based assays to specialist cell culture systems customised to meet customers’ requirements.
Technology:
P4 Medicine
Industry:
Personalized Medicine
Headquarters:
Ayr, South Ayrshire, United Kingdom
Founded Date:
2006
Employees Number:
11-50
Funding Status:
N/A
Investors Number:
1
Total Funding:
â¬1.3M
Estimated Revenue:
$1M to $10M
Last Funding Type:
Grant
Register and Claim Ownership